TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
OPT

Opthea Ltd

Healthcare · Biotechnology

3.40$ +7.2% vs. previous close Closing price · As of: Jul 2, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement OPT
Line item 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
243.5% 354.5% 621.8% 185.9% 155.4% 82.6%
-143.5% -254.5% -521.8% -85.9% -55.4% 17.4%
27,865.5% 11,981.4% 37,736.2% 86,735.4% 112,658.3% 141,439.0%
4,522.3% 4,530.3% 12,913.7% 13,039.1% 11,957.1% 12,424.1%
32,237.0% 16,939.3% 57,760.2% 106,589.6% 138,654.6% 153,985.4%
-32,595.3% -16,929.7% -57,815.7% -106,576.0% -138,648.0% -153,885.4%
972.4% 9.9% 23,542.7% 188.3% 8,353.1% 24,275.3%
-31,598.2% -16,716.7% -73,285.7% -109,300.2% -136,936.6% -184,215.7%
13,011.0% 5,669.7% -7,198.1% -6,946.5% -5,466.8% -7,549.9%
-18,587.2% -11,047.0% -66,087.6% -102,353.7% -131,469.8% -176,665.7%
-32,565.8% -17,079.2% -57,455.8% -106,489.6% -138,554.6% -160,443.7%

Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?